Ibogaine Treatment is an independent information resource. Our mission is simple: to gather, summarise, and explain the evidence, legal context, and safety considerations related to ibogaine so people, families, and professionals can make better-informed judgments.
Why this resource exists
We created this resource because questions about ibogaine often combine scientific uncertainty, evolving law, and lived experience. By concentrating on clarity and evidence-aware context, Ibogaine treatment aims to reduce confusion for readers seeking practical orientation rather than promotional claims.
Our editorial approach
We assemble material from peer-reviewed literature, registries, and official guidance, and we describe our methods plainly so readers can assess the basis for each statement. For claims about safety and regulation we cross-check public health guidance such as the National Institutes of Health and established academic summaries; for example, readers will find context consistent with summaries found on major educational resources like the National Institutes of Health (https://www.nih.gov) when we reference pharmacology or trial evidence.
How information is sourced and vetted
Our fact-checking process favours primary sources and recognized repositories: clinical registries, indexed journal articles, and government advisories. Where synthesis is required we clearly identify uncertainty and link to source material; authoritative summaries such as those on encyclopedic pages like Wikipedia (https://en.wikipedia.org/wiki/Ibogaine) are used when they add reliable background, and we consult academic repositories hosted by universities for methodological context (for example, guidance found at https://www.harvard.edu can illuminate how we interpret evidence synthesis).
We prioritise transparency: what the evidence shows, where it is thin, and what questions remain unanswered.
What we cover
Ibogaine treatment organises content into topical sections: policy and legal context, safety considerations, research and evidence summaries, and practical questions readers commonly ask. Each page is structured to present plain-language summaries up front, followed by the evidence and links to source materials.
Our site also includes pathways for readers who want service-oriented information: for example, our services overview explains the kinds of logistical questions people might consider; that page links naturally to the broader homepage and other explanatory resources where appropriate. A reader curious about available programs may read our description on service considerations while still finding contextual links back to the main site narrative at Ibogaine treatment's homepage.
Editorial principles
- Independence — we make no treatment claims and accept no clinical referrals.
- Plain language — technical topics are translated into clear summaries for non-specialists.
- Risk awareness — we foreground safety uncertainties and practical harms where present.
- Evidence context — statements are linked to source material and qualified by confidence.
- Cultural respect — we acknowledge traditional contexts while focusing on contemporary evidence.
Who this is for
This resource is for people researching ibogaine, including family members, advocates, and professionals seeking clear context rather than clinical advice. We do not provide medical, legal, or treatment services, and our pages are intended to inform decision-making rather than replace professional consultation.
Independent by design
Ibogaine Treatment is an independent information resource, not a clinic, medical provider, or licensed treatment center. Its content is not medical or legal advice. Readers should consult qualified professionals for personal medical or legal questions.
— The editorial collective, Ibogaine treatment